Fundraising Fox

Aberdare Ventures

Venture capital

San Francisco · Seed–Series A · 2 people tracked

Also known as ABERDARE MANAGEMENT COMPANY, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Aberdare Ventures is a venture capital firm based in Menlo Park, California. It invests exclusively in companies working to make healthcare more efficient, lower cost, and smarter.

Invests inHealthtechBrazilMenlo ParkSan FranciscoUnited States

Source: firm website, verified Aug 11, 2026.

Stage
Seed–Series A
Check
$500K – $15M
HQ
San Francisco, CA, US
Leads rounds
Follows
Instruments
Equity
Founded
1999
Private fund assets
$28.6M
VC funds
1
Tracked investments
1

Team · 2 people

from public directories
Paul Klingenstein· Managing Partnerin

What they invest in

from 1 of 1 portfolio companies

Healthtech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Autonomic TechnologiesMay 2015SEC filingmedium confidence

HealthtechRedwood City, US

Niamh Pellegrini(Executive Officer, Director)Reza Zadno(Director)Craig Patterson(Executive Officer)

BoardDana Mead(Director)Sigrid Van Bladel(Director)Martien van Osch(Director)

Board seatSigrid Van Bladel· per SEC Form D · $48.2M raise · filed Jun 2016

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Fund performance · per public LP disclosures · 2

as of Sep 2021
FundVintageCommittedNet IRRTVPIDPI
Aberdare Ventures IV, LPLPs: California Public Employees' Retirement System2008-0.2%0.99x0.46x
Aberdare Ventures III, LPLPs: California Public Employees' Retirement System20052.7%1.17x0.98x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Public market activity · per SEC filings

what is this? ⓘ
SC 13D/A filingSC 13D/A

Disclosed stake · filed Jul 2013

view filing ↗
SC 13D filingSC 13D

Disclosed stake · filed Apr 2012

view filing ↗

From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

What stage does Aberdare Ventures invest at?
Aberdare Ventures invests at the Seed, Series A stages.
What is Aberdare Ventures's typical check size?
Aberdare Ventures typically writes checks of $500K – $15M.
What sectors does Aberdare Ventures focus on?
Aberdare Ventures focuses on Healthtech.
Where is Aberdare Ventures located?
Aberdare Ventures is headquartered in San Francisco, US.
Does Aberdare Ventures lead rounds?
Aberdare Ventures typically participates in rounds rather than leading them.

Images

Aberdare Ventures photo

Co-investors · 7

Breakthrough Energy Ventures

Breakthrough Energy is a global platform founded to accelerate clean energy innovation and build climate-focused industries, supporting innovators developing affordable, reliable, clean energy technologies.

$500K – $50M
MassMutual Ventures

MassMutual Ventures is a global venture capital firm partnering with technology companies across enterprise SaaS, fintech, cybersecurity, healthtech, and climate technology.

$500K – $5M
OUP (Osage University Partners)

OUP (Osage University Partners) is a venture capital firm that backs startups spinning out of leading research labs and universities, partnering with founders, researchers, and academic institutions.

$1M – $20M
Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.

Advent Life Sciences

Advent Life Sciences is a trans-Atlantic venture capital firm investing in early and mid-stage life sciences companies across the UK, Europe and the USA.

ACORN BIOVENTURES

Acorn Bioventures invests across multiple stages in small-cap public and private biotechnology companies developing novel innovative medicines. The firm offers flexible capital structures including seed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, and open market purchases.

Firms observed investing alongside Aberdare Ventures, from public investor directories. Shared companies are the overlap with Aberdare Ventures's recorded portfolio.

Similar investors

Featured in lists